MEDVi Review 2026
Independent review of MEDVi's GLP-1 program, pricing, medications, and who it's best for.
Last updated March 2026 · Read our methodology
Pros
- Injectable AND dissolvable tablet options for both semaglutide and tirzepatide — unique in market
- Fast approval — most patients start within days
- 24/7 unlimited messaging with licensed care team
- No long-term contracts — cancel anytime with 72-hour notice
- Results guarantee: refund if no weight loss after 5+ months of adherence
- 100,000+ patients served across 49 states
- Transparent cash-pay pricing with no hidden fees
Cons
- Compounded medications only — no brand-name Wegovy or Zepbound
- Refill pricing jumps significantly ($179 first month → $299 for semaglutide refills)
- Outcome data is self-reported (15–20% weight loss claims not independently verified)
- Occasional billing and double-charge complaints noted in reviews
- Not available in North Dakota; tablet form restricted in Alabama and California
What They Offer
MEDVi is a telehealth platform offering compounded semaglutide and tirzepatide through its partner network, OpenLoop Health (a network of U.S.-licensed physicians). Unlike most competitors, MEDVi offers both injectable and dissolvable tablet formats for each medication — a genuinely differentiated option for patients who prefer oral administration or struggle with injections. The platform is entirely cash-pay and ships medication direct to home from licensed pharmacies.
Pricing & Plans
| Plan | Price | Includes |
|---|---|---|
| Semaglutide Injections — First Month | $179 | Medication, physician review, shipping, coaching, 24/7 messaging |
| Semaglutide Injections — Refills | $299/mo | Medication, shipping, ongoing support |
| Semaglutide Tablets — First Month | $249 | Dissolvable tablet form, physician review, shipping |
| Semaglutide Tablets — Refills | $369/mo | Dissolvable tablets, ongoing support |
| Tirzepatide (Injections or Tablets) — First Month | $279 | Medication, physician review, shipping |
| Tirzepatide (Injections or Tablets) — Refills | $399/mo | Medication, ongoing support |
What's Included
- Physician review and clinical evaluation by OpenLoop Health providers
- Personalized weight loss plan and metabolic report
- One-on-one coaching with care team
- GLP-1 medication prescribed and shipped directly to home
- Free shipping on all orders
- Unlimited 24/7 messaging with care team
- Dosing guidance and side effect management
- No membership or subscription fees beyond medication cost
- Refund guarantee if no weight loss after 5+ months with adherence
Eligibility
BMI 30+ OR BMI 27+ with at least one weight-related condition (e.g., hypertension, high cholesterol, pre-diabetes). Age 18+. Available in 49 states (North Dakota excluded). Six states require a pre-prescription video appointment: Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia. Injectable-only in Alabama and California.
Clinical Results & Effectiveness
MEDVi reports that 85% of patients lose at least 5% of body weight within 3 months, and average weight loss across the program is 15–20% of body weight. These figures are based on patient self-reporting (weight logged every 3–4 weeks) and have not been independently verified in a peer-reviewed study. MEDVi's network has served 100,000+ patients, making their dataset meaningful in volume, though selection bias is likely (motivated patients who complete check-ins may skew outcomes). The compounded semaglutide and tirzepatide use the same active ingredients as brand-name medications but are not FDA-approved as finished products.
Customer Experience
MEDVi holds a 4.5-star rating on Trustpilot with over 10,000 reviews — one of the highest review volumes of any GLP-1 telehealth platform. Common praise focuses on quick approval, clear communication, and responsive care team access. Complaints, while a small minority, include occasional billing errors (double charges reported by some users), delayed prescriptions, and infrequent provider no-shows. The company responds to 100% of negative Trustpilot feedback.
Our Verdict
MEDVi's biggest differentiator is genuine: offering both injectable and dissolvable tablet forms for semaglutide and tirzepatide addresses a real patient need. Their fast approval process, 24/7 care team access, and no-contract model make it easy to start and easy to leave. The main watch-out is the refill price jump — $179 becomes $299 for semaglutide, which is less competitive than flat-rate competitors. The results guarantee (refund after 5+ months with no weight loss) is a strong confidence signal.
Get Started with MEDVi →References
Get the GLP-1 Insider Brief
Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.